Impact of daclizumab, low-dose cyclosporine, mycophenolate mofetil and steroids on renal function after kidney transplantation
Options
BORIS DOI
Date of Publication
2010
Publication Type
Article
Division/Institute
Author
Fangmann, Josef | |
Arns, Wolfgang | |
Hauss, Johann | |
Ketteler, Markus | |
Beckurts, Tobias | |
Boesmueller, Claudia | |
Pohanka, Erich | |
Martin, Pierre-Yves | |
Gerhardt, Moritz | |
Farese, Stefan | |
Neumayer, Hans-H | |
Floege, Juergen | |
Gurr, Caroline | |
Budde, Klemens | |
DACH Study Group |
Series
Nephrology, dialysis, transplantation
ISSN or ISBN (if monograph)
0931-0509
Publisher
Oxford University Press
Language
English
Publisher DOI
PubMed ID
19773417
Description
Early and long-term use of cyclosporine A (CsA) leads to increased risks of renal toxicity. We hypothesized that administration of daclizumab in combination with mycophenolate mofetil (MMF) allows a relevant reduction in the dose of CsA.
File(s)
| File | File Type | Format | Size | License | Publisher/Copright statement | Content | |
|---|---|---|---|---|---|---|---|
| gfp468.pdf | text | Adobe PDF | 364.24 KB | publisher | published |